(4R,5S)-Nutlin carboxylic acid|CAS 2306390-08-7|DC Chemicals

Cas No.:	2306390-08-7
Chemical Name:	(4R,5S)-Nutlin carboxylic acid
Synonyms:	(4R,5S)-nutlin carboxylic acid;2-(4-((4R,5S)-4,5-Bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydro-1H-imidazole-1-carbonyl)-2-oxopiperazin-1-yl)acetic acid
SMILES:	ClC1C([H])=C([H])C(=C([H])C=1[H])[C@@]1([H])[C@@]([H])(C2C([H])=C([H])C(=C([H])C=2[H])Cl)N=C(C2C([H])=C([H])C(=C([H])C=2OC([H])(C([H])([H])[H])C([H])([H])[H])OC([H])([H])[H])N1C(N1C([H])([H])C(N(C([H])([H])C(=O)O[H])C([H])([H])C1([H])[H])=O)=O
Formula:	C₃₂H₃₂Cl₂N₄O₆
M.Wt:	639.5257
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC67845	N-Me-Thalidomide 4-fluoride	N-Me-Thalidomide 4-fluoride is a ligand for E3 ligase, used for the synthesis of Anti-inflammatory agent 70 .
DC67844	CRBN ligand-880	CRBN ligand-880 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein. CRBN ligand-880 can be linked to a target protein ligand via a linker to form a PROTAC.
DC67843	6-hydroxy-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
DC67842	Tert-butyl 4-(4-aMino-3-Methoxyphenyl)piperazine-1-carboxylate
DC67841	Boc-NH-PEG4	Boc-NH-PEG4 (PROTAC Linker 12) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.
DC67840	tert-Butyl (6-hydroxyhexyl)carbamate	tert-Butyl (6-hydroxyhexyl)carbamate is a PROTAC linker that can be used in the synthesis of PROTACs.
DC67839	tert-Butyl N-(2,6-dioxopiperidin-3-yl)carbamate (Standard)	tert-Butyl N-(2,6-dioxopiperidin-3-yl)carbamate (Standard) is the analytical standard of tert-Butyl N-(2,6-dioxopiperidin-3-yl)carbamate. This product is intended for research and analytical applications.
DC67838	3-amino-1-methylpiperidine-2,6-dione hydrochloride
DC67837	(S)-3-Amino-piperidine-2,6-dione hydrochloride
DC67836	(R)-3-Aminopyrrolidine-2,5-dione	(R)-3-Aminopyrrolidine-2,5-dione is a potential anticonvulsant agent and its derivatives have comparable in vivo efficacy.